397
Participants
Start Date
November 30, 2006
Primary Completion Date
September 30, 2007
Study Completion Date
September 30, 2007
Azithromycin plus Chloroquine
Azithromycin 1000 mg by mouth (PO) (two 500 mg tablets) once daily (QD) for 3 days(Days 0, 1, 2) plus chloroquine 600 mg base PO once daily for 3 days (Days 0, 1, 2)
Mefloquine
Mefloquine 1250 mg PO given as a split dose (750 mg \[three 250 mg capsules\]) initial dose followed by 500 mg PO (two 250 mg capsules) given 6 to 10 hours later on Day 0
Pfizer Investigational Site, Kisumu
Pfizer Investigational Site, Ouagadougou
Pfizer Investigational Site, Nouna
Pfizer Investigational Site, Navrongo
Pfizer Investigational Site, Bamako
Pfizer Investigational Site, Bamako
Pfizer Investigational Site, Senegal
Pfizer Investigational Site, Ndola
Lead Sponsor
Pfizer
INDUSTRY